No Data
No Data
Earnings Call Summary | Avid Bioservices(CDMO.US) Q4 2024 Earnings Conference
The following is a summary of the Avid Bioservices, Inc. (CDMO) Q4 2024 Earnings Call Transcript:Financial Performance:Avid Bioservices reported Q4 FY2024 revenue of $43 million, an 8% increase year-o
Avid Bioservices Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/03/2024 19.4% RBC Capital $8 → $8 Reiterates Outperform → Outperform 04/30/2024 19.4% RBC Capital $7 →
Why Avid Bioservices Stock Is Moving Higher Wednesday
Avid Bioservices, Inc. (NASDAQ:CDMO) shares are trading higher on Wednesday following the company reporting better-than-expected 2024 fiscal-year fourth quarter sales.The Details: Avid reported fourth
Avid Bioservices Shares Rise on Upbeat FY25 Outlook
By Michael Susin Avid Bioservices shares rose on Wednesday after the group said it expects revenue to sharply increase in fiscal 2025 and to generate positive cashflow and despite posting a widened f
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Buy Rating, Announces Target Price $16
Craig-Hallum analyst Matt Hewitt maintains $Avid Bioservices(CDMO.US)$ with a buy rating, and sets the target price at $16.According to TipRanks data, the analyst has a success rate of 39.4% and a tot
RBC Capital Maintains Avid Bioservices(CDMO.US) With Buy Rating, Maintains Target Price $8
RBC Capital analyst Sean Dodge maintains $Avid Bioservices(CDMO.US)$ with a buy rating, and maintains the target price at $8.According to TipRanks data, the analyst has a success rate of 39.2% and a t
No Data